The FDA have approved sales of a two-drug combination treatment produced by Schering-Plough.  The antiviral pill Rebetol and PEG-intron will be administered together as the first long-term treatment for children aged 3-17 years old infected with hepatitis C. Full story at The...

Following a three and a half year long study, it has been concluded that interferon should no longer be used to treat chronic liver disease resulting from HCV.  It has been shown by UT Southwestern Medical Center researchers that when used alone, the drug has no effect on halting disease...

Hepatitis C test results are being misinterpreted by over a third of GPs who routinely prescribe the test.  A survey by ICM healthcare also found that in some cases there is no patient follow-up which is putting people at risk of fatal liver damage. Full story at Times online